These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10966954)

  • 1. Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
    van Beek LM; Mulder M; van Haeringen NJ; Kijlstra A
    Br J Ophthalmol; 2000 Sep; 84(9):1004-7. PubMed ID: 10966954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 3. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.
    Wood JP; Schmidt KG; Melena J; Chidlow G; Allmeier H; Osborne NN
    Exp Eye Res; 2003 Apr; 76(4):505-16. PubMed ID: 12634114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
    Hayashi-Morimoto R; Yoshitomi T; Ishikawa H; Hayashi E; Sato Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Aug; 237(8):661-7. PubMed ID: 10459616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ophthalmic beta blockers: a comparative review.
    Zimmerman TJ
    J Ocul Pharmacol; 1993; 9(4):373-84. PubMed ID: 7906296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
    Sato T; Muto T; Ishibashi Y; Roy S
    Curr Eye Res; 2001 Oct; 23(4):298-306. PubMed ID: 11852432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
    James IM
    Surv Ophthalmol; 1989 Apr; 33 Suppl():453-4; discussion 459-60. PubMed ID: 2568696
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Frishman WH; Fuksbrumer MS; Tannenbaum M
    J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.
    Berlin I; Marcel P; Uzzan B; Millon D; Le Hoang P; Puech AJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):622-6. PubMed ID: 2884059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery.
    Hester RK; Chen Z; Becker EJ; McLaughlin M; DeSantis L
    Surv Ophthalmol; 1994 May; 38 Suppl():S125-34. PubMed ID: 7940134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    Chidlow G; Melena J; Osborne NN
    Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
    Wu KY; Hong SJ; Wang HZ
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):13-21. PubMed ID: 9029436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes].
    Höh H
    Klin Monbl Augenheilkd; 1989 Apr; 194(4):241-8. PubMed ID: 2566707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutrophil migration and oxygen free radical release by metipranolol and timolol.
    Djanani A; Kaneider NC; Meierhofer C; Sturn D; Dunzendorfer S; Allmeier H; Wiedermann CJ
    Pharmacology; 2003 Aug; 68(4):198-203. PubMed ID: 12837974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
    Blondin C; Hamard P; Cholley B; Haeffner-Cavaillon N; Baudouin C
    Curr Eye Res; 2003 Oct; 27(4):253-9. PubMed ID: 14562177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.